The Course of Acute Respiratory Failure in Geriatric Patients With Hip Fracture Using Different Modes of a Vibroacoustic Device for the Lungs

Astana Medical University

Status: Enrolling

Conditions: Vibration; Respiratory Complications

Treatments: Device: Vibrolung

Study type: Interventional

Funder types: Other

Identifiers

NCT07517497

Grant No.AP25795127 (Other Grant/Funding Number)

AP25795127

Details and patient eligibility

About

A medical professional trained in the procedure and use of the device will conduct the vibroacoustic therapy session. He will also take blood samples.

In the control group, patients will undergo vibroacoustic pulmonary therapy in the "Pneumonia" mode, and in the control group, in the "Prevention" mode. Vibroacoustic pulmonary therapy will be conducted over a period of 5 days. A similar algorithm of actions is planned for both groups. VALT sessions will be conducted 4-6 times a day for 5 minutes in combination with treatment according to the protocol for the use of "Vibroacoustic Therapy" of the lungs of the Ministry of Health of the Republic of Kazakhstan. The device's emitters will be applied to the affected areas of the lungs. Since the device has long cords for the emitters and is portable, it is not difficult to change the patient's position and does not require their active participation, which is important for patients on ventilators and with limited mobility.

Enrollment: 60 estimated patients

Sex: All

Ages: 60 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

• respiratory failure;
• hip fracture;
• Injury Severity Score no higher than 8 points.

Exclusion Criteria:

• All contraindications for use of the device:
• terminal condition of the patient;
• shock;
• paradoxical pathological breathing;
• hypertensive crisis;
• severe hypocoagulation with a risk of hematoma formation or bleeding in the projection of exposure;
• severe hypercoagulation, risk of thrombus/embolus migration along the main vessels in the area of exposure;
• acute cerebrovascular accident in the first 1-3 days;
• brain edema;
• presence of multiple purulent or burn wound surfaces in the area of exposure;
• presence of unstable rib fractures;
• pneumomediastinum and/or subcutaneous emphysema of the chest;
• osteomyelitis of the ribs and/or thoracic spine;
• spinal fracture without orthopedic fixation;
• chest or abdominal trauma with bleeding;
• Injury Severity Score greater than 8 points;
• concomitant diseases in the stage of decompensation.

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

60 participants in 2 patient groups

patients will undergo Vibrolung in the "Pneumonia" mode.

Other group

Description:

vibroacoustic physiotherapy

Treatment:

Device: Vibrolung

patients will undergo vibroacoustic pulmonary therapy in the "Prevention" mode.

Other group

Description:

vibroacoustic physiotherapy

Treatment:

Device: Vibrolung